The Use of Recombinant Human Bone Morphogenic Protein-2 (rhBMP-2) in Treatment for Cysts of the Oral and Maxillofacial Regions
이종범, Kim Taek-Woo, 류석환, 신동윤, 류현호, 박석용, Shin Young-Cho, 김복주, 황희성, 김철훈,
소속 상세정보
이종범 ( Lee Jong-Bum ) - Dong-A University Medical Center Department of Oral and Maxillofacial Surgery
( Kim Taek-Woo ) - Dong-A University Medical Center Department of Oral and Maxillofacial Surgery
류석환 ( Ryu Seok-Hwan ) - Dong-A University Medical Center Department of Oral and Maxillofacial Surgery
신동윤 ( Shin Dong-Yoon ) - Dong-A University Medical Center Department of Oral and Maxillofacial Surgery
류현호 ( Ryu Hyun-Ho ) - Dong-A University Medical Center Department of Oral and Maxillofacial Surgery
박석용 ( Park Seok-Yong ) - Dong-A University Medical Center Department of Oral and Maxillofacial Surgery
( Shin Young-Cho ) - Dong-A University Medical Center Department of Oral and Maxillofacial Surgery
김복주 ( Kim Bok-Joo ) - Dong-A University School of Medicine Department of Oral and Maxillofacial Surgery
황희성 ( Hwang Hee-Seong ) - Dong-A University Medical Center Department of Oral and Maxillofacial Surgery
김철훈 ( Kim Chul-Hoon ) - Dong-A University Medical Center Department of Oral and Maxillofacial Surgery
KMID : 1036320140360010025
Abstract
The purpose of this study is to report on five cases treated with bone graft using recombinant human bone morphogenetic
protein-2 (rhBMP-2) on jaw defects after cyst enucleation. We performed bone graft with BMP (rhBMP-2+β-tricalcium phosphate/hydroxyapatite)
wrapped with a collagen sponge on jaw defects after cyst enucleation. Postoperative panoramic radiographs
were taken periodically. After 1 to 12 months, bone remodeling was observed in the jaw defect area. In our cases, there
were few signs or symptoms of recurrence of the cyst during the follow-up period.
키워드
rhBMP-2; Bone transplantation; Odontogenic cysts
원문 및 링크아웃 정보
등재저널 정보